Israel’s Filterex Medical has completed successful trials of its CAPTIS device. The easily deployed device protected 20 patients during Transcatheter Aortic Valve Replacement (TAVR) procedures, preventing any embolic particles (debris) entering the bloodstream and causing a stroke.

https://filterlex.com/2022/06/02/filterlex-medical-announces-positive-results-from-a-first-in-human-study-for-the-captis-full-body-embolic-protection-device/

https://www.youtube.com/watch?v=EFv7QZNsch8